Displaying drugs 2601 - 2625 of 2785 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Piperazine | 86.1356 C4H10N2 | A medication used to treat roundworm and pinworm. | Piperazine and Derivatives | |
Isopropyl myristate | 270.4507 C17H34O2 | A polar skin moisturizer that is used to enhance skin penetration of drugs. | Fatty Acids / Lipids / Myristic Acids / Scabicides and Pediculicides | |
Succinic acid | 118.088 C4H6O4 | For nutritional supplementation, also for treating dietary shortage or imbalance | Succinates | |
Granisetron | 312.417 C18H24N4O | A 5HT3 antagonist used to treat nausea and vomiting in cancer therapy and postoperatively. | Antiemetics / Azabicyclo Compounds / Indazoles / Serotonin 5-HT3 Receptor Antagonists / Serotonin Receptor Antagonists | |
Tovorafenib | 506.29 C17H12Cl2F3N7O2S | A type II RAF inhibitor used to treat pediatric low-grade glioma with BRAF gene mutations. | B-Raf serine-threonine kinase (BRAF) inhibitors / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inducers / Cytochrome P-450 CYP1A2 Inducers (strength unknown) / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Heterocyclic Compounds, Fused-Ring / Sulfur Compounds | |
Technetium Tc-99m sestamibi | 775.96 C36H66N6O6Tc | A radiopharmaceutical diagnostic agent used in nuclear medicine imaging tests to detect coronary artery disease and evaluate myocardial function. | Technetium (99Mtc) Compounds | |
Glasdegib | 374.448 C21H22N6O | A sonic hedgehog receptor inhibitor used to treat newly diagnosed acute myeloid leukemia in patients over 75 years who cannot receive intense chemotherapy. | Hedgehog pathway inhibitors | |
Lapyrium | 363.521 C21H35N2O3 | Used as a surfactant, antistatic agent, and biocide in cosmetic products . | Pyridines | |
Lorpiprazole | 405.469 C21H26F3N5 | In 2016, lorpiprazole was classified in the "Chemical structure-related drug-like criteria of global approved drugs" as an antipsychotic and anxiolytic. An antipsychotic is a medication used to treat a state... | Antidepressive Agents / Central Nervous System Depressants / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Drugs that are Mainly Renally Excreted / Serotonin 5-HT2 Receptor Antagonists / Serotonin 5-HT2A Receptor Antagonists / Serotonin 5-HT2C Receptor Antagonists / Serotonin Agents / Serotonin Modulators / Serotonin Receptor Antagonists | |
Lanreotide | 1096.33 C54H69N11O10S2 | A somatostatin analog used for the treatment of unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors and acromegaly. | Acromegaly / Antineoplastic Agents / Somatostatin and Analogues | |
Mizolastine | 432.503 C24H25FN6O | A second-generation non-sedating antihistamine used to treat symptoms of allergic rhinoconjunctivitis and urticaria. | Histamine H1 Antagonists, Non-Sedating | |
Meticrane | 275.34 C10H13NO4S2 | Meticrane is a diuretic medication. It has been marketed in Japan under the trade name Arresten and is used to lower blood pressure . | Sulfonamides | |
Bucetin | 223.272 C12H17NO3 | Bucetin is an analgesic and antipyretic medication which was approved for use in Germany but was withdrawn from the market in 1986 due to renal toxicity caused by the medication. | Anilides | |
Migalastat | 163.1717 C6H13NO4 | An alpha-galactosidase A chaperone used for the treatment of Fabry disease in patients with an amenable galactosidase alpha gene (GLA) variant. | Various Alimentary Tract and Metabolism Products | |
Phenol | 94.1112 C6H6O | An antiseptic and disinfectant used in a variety of settings. | Phenol and Derivatives / Sclerosing Agents for Local Injection | |
Resorcinol | 110.1106 C6H6O2 | Contemporary therapeutic uses for resorcinol primarily revolve around the use of the phenol derivative as an active ingredient in topical antiseptics [L2745, L2744, L40069, F61] or as topical antibacterial skin... | Root Canal Filling Materials | |
Exemestane | 296.4034 C20H24O2 | An aromatase inhibitor used to treat breast cancer in postmenopausal women after treatment with tamoxifen. | Antineoplastic Agents / Aromatase Inhibitors | |
Ioxilan | 791.116 C18H24I3N3O8 | A diagnostic contrast agent used in various medical imaging procedures, such as angiography, urography, and computed tomographic scans. | Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media | |
Zafirlukast | 575.675 C31H33N3O6S | A leukotriene receptor antagonist used for prophylaxis and chronic treatment of asthma. | Anti-Asthmatic Agents / Leukotriene Antagonists | |
Eplerenone | 414.4914 C24H30O6 | An aldosterone receptor antagonist used to improve survival of patients with symptomatic heart failure and to reduce blood pressure. | Antihypertensive Agents / Antihypertensive Agents Indicated for Hypertension / Lactones / Mineralocorticoid Receptor Antagonists / Pregnenes | |
Ziconotide | 2639.14 C102H172N36O32S7 | An N-type calcium channel antagonist used to manage patients with severe chronic pain who cannot tolerate, or who have not responded adequately to other treatments such as intrathecal morphine and systemic analgesics. | Analgesics | |
Ixazomib | 361.03 C14H19BCl2N2O4 | A monoclonal antibody used with other medications to treat multiple myeloma in patients who have received one other therapy already. | Proteasome Inhibitors | |
Cevimeline | 199.313 C10H17NOS | A muscarinic agonist with parasympathomimetic activities that is used for the symptomatic treatment of dry mouth in patients with Sjögren's Syndrome. | Parasympathomimetics | |
Butylene glycol | 90.121 C4H10O2 | Not Annotated | Alcohols / Glycols | |
Hydroxycitronellal | 172.2646 C10H20O2 | Hydroxycitronellal is approved by the FDA for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in... | Perfume / Standardized Chemical Allergen |
Displaying drugs 2601 - 2625 of 2785 in total